| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $5.96 (Beat by $5.33) |
| EPS GAAP Actual | $5.96 (Beat by $5.33) |
| Revenue Actual | $0.817904B |
| Revenue Surprise | Beat by $817.904M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $4.1935 |
| EPS GAAP Estimate | $4.1935 |
| Revenue Estimate | $0.5927043B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2030 | 3.91 | 32.25 | 3.91 | 3.91 | 1 |
| Oct 2029 | 3.91 | 32.25 | 3.91 | 3.91 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.51 | -4.39 | 0.817904B | -19.77% | 24.26M |
| FQ3 2025 (Jul 2025) | 2.14 | -0.91 | 0.800583B | 9.73% | 63.12M |
| FQ2 2025 (Apr 2025) | 2.64 | 2.64 | 0.686471B | -3.19% | 686.47M |
| FQ1 2025 (Jan 2025) | 4.33 | 4.33 | 0.673623B | 11.79% | 673.62M |
| FQ4 2024 (Oct 2024) | 14.54 | 14.54 | 0.979638B | 9.45% | 979.64M |
| FQ3 2024 (Jul 2024) | 11.26 | 11.26 | 0.722704B | 10.07% | 722.7M |
| FQ2 2024 (Apr 2024) | 7.87 | 7.87 | 0.70838B | 0.67% | 708.38M |
| FQ1 2024 (Jan 2024) | 3.06 | 3.06 | 0.594196B | 13.27% | 594.2M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
4.1935
Consensus Revenue Estimates
0.5927043B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Apr 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Jan 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Oct 2026) | 11.713 | 104.35 | 11.713 | 11.713 | 1 |
| FQ3 2026 (Jul 2026) | 9.5287 | 77.54 | 9.5287 | 9.5287 | 1 |
| FQ2 2026 (Apr 2026) | -0.16 | 1750 | -0.16 | -0.16 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.98B | -- | 0.98B | 0.98B | 1 |
| FQ3 2027 (Jul 2027) | 0.89B | -- | 0.89B | 0.89B | 1 |
| FQ2 2027 (Apr 2027) | 0.76B | -- | 0.76B | 0.76B | 1 |
| FQ1 2027 (Jan 2027) | 0.62B | -- | 0.62B | 0.62B | 1 |
| FQ4 2026 (Oct 2026) | 0.87B | 5.83 | 0.87B | 0.87B | 1 |
| FQ3 2026 (Jul 2026) | 0.8B | -0.2 | 0.8B | 0.8B | 1 |
| FQ2 2026 (Apr 2026) | 0.53B | -29.47 | 0.53B | 0.53B | 14 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 3.88 | -0.51 | -4.39 | 860.78% |
| FQ3 2025 (Jul 2025) | 3.05 | 2.14 | -0.91 | -42.52% |
| FQ2 2025 (Apr 2025) | 2.64 | 2.64 | 100% | |
| FQ1 2025 (Jan 2025) | 4.33 | 4.33 | 100% | |
| FQ4 2024 (Oct 2024) | 14.54 | 14.54 | 100% | |
| FQ3 2024 (Jul 2024) | 11.26 | 11.26 | 100% | |
| FQ2 2024 (Apr 2024) | 7.87 | 7.87 | 100% | |
| FQ1 2024 (Jan 2024) | 3.06 | 3.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.79B | $0.82B | $24.26M | 2.97% |
| FQ3 2025 (Jul 2025) | $0.74B | $0.8B | $63.12M | 7.88% |
| FQ2 2025 (Apr 2025) | $0B | $0.69B | $686.47M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.67B | $673.62M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.98B | $979.64M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.72B | $722.7M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.71B | $708.38M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.59B | $594.2M | 100% |